The Combination of Sinusoidal Perfusion Enhancement and Apoptosis Inhibition by Riociguat Plus a Galactose-PEGylated Bilirubin Multiplexing Nanomedicine Ameliorates Liver Fibrosis Progression
Abstract
Research context
OpenAlex topics: Liver physiology and pathology · Liver Disease Diagnosis and Treatment · Organ Transplantation Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, China
School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
College of Chemistry, Zhengzhou University, Zhengzhou 450001, China
GBA Research Innovation Institute for Nanotechnology, Guangzhou 510530, China
Funding
Guangdong Science and Technology Department · Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China · Beijing Nova Program · Chinese Academy of Sciences